178
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Lamotrigine—A Review of Analytical Methods Developed for Pharmaceutical Formulations and Biological Matrices

, &
Pages 1451-1460 | Published online: 05 Mar 2021

References

  • Goldengerg, M. M. Overview of Drugs Used for Epilepsy and Seizures Etiology, Diagnosis, and Treatment. Pharm. Ther. 2010, 35, 392–415.
  • Yuen, A. W. C. Lamotrigine: A Review of Antiepileptic Efficacy. Epilepsia 1994, 35, 5, S33–S36. DOI: 10.1111/j.1528-1157.1994.tb05964.x.
  • Yasam, V. R.; Jakki, S. L.; Senthil, V.; Eswaramoorthy, M.; Shanmuganathan, S.; Arjunan, K.; Nanjan, M. J. A Pharmacological Overview of Lamotrigine for the Treatment of Epilepsy. Expert Rev. Clin. Pharmacol. 2016, 9, 1533–1546. DOI: 10.1080/17512433.2016.1254041.
  • Brodie, M. J. Lamotrigine. Lancet 1992, 339, 1397–1400. DOI: 10.1016/0140-6736(92)91207-O.
  • Frank, J. E. V.; Seetal, D.; David, H. Lamotrigine in Epilepsy, Pregnancy and Psychiatry – A Drug for All Seasons? J. Clin. Neurosci. 2013, 20, 13–16. DOI: 10.1016/j.jocn.2012.05.024.
  • Goa, K. L.; Ross, S. R.; Chrisp, P. Lamotrigine. A Review of Its Pharmacological Properties and Clinical Efficacy in Epilepsy. Drugs 1993, 46, 152–176. DOI: 10.2165/00003495-199346010-00009.
  • www.pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine (accessed Sept 17, 2020).
  • Berk, M. Lamotrigine and the Treatment of Mania in Bipolar Disorder. Eur. Neuropsychopharmacol. 1999, 9, S119–S123. DOI: 10.1016/S0924-977X(99)00025-5.
  • https://go.drugbank.com/drugs/DB00555 (accessed Sept 1, 2020).
  • Barrera-Bailon, B.; Oliveira, J. A. C.; Lopez, D. E.; Munoz, L. J.; Garcia-Cairasco, N.; Sancho, C. Pharmacological and Neuroethological Study of the Acute and Chronic Effects of Lamotrigine in the Genetic Audiogenic Seizure Hamster (GASH:Sal). Epilepsy Behav. 2017, 71, 207–217. DOI: 10.1016/j.yebeh.2015.11.005.
  • Peck, A. W. Clinical Pharmacology of Lamotrigine. Epilepsia 1991, 32, S9–S12. DOI: 10.1111/j.1528-1157.1991.tb05883.x.
  • Vijaya Bhaskara Reddy, T.; Ramu, G.; Biksham Babu, A.; Rambabu, C. Development and Validation of HLPC Method for the Estimation of Lamotrigine in Bulk and Pharmaceutical Formulations. J. Chem. 2013, 2013, 1–4. DOI: 10.1155/2013/846170.
  • Masoom, R. S.; Zeid, A. A.; Nafisur, R. Analytical Techniques in Pharmaceutical Analysis: A Review. Arab. J. Chem. 2017, 10, S1409–S1421. DOI: 10.1016/j.arabjc.2013.04.016.
  • Nadia, F. Y.; Elham, A. T. Development and Validation of Spectrophotometric, TLC and HPLC Methods for the Determination of Lamotrigine in Presence of Its Impurity. Chem. Pharm. 2007, 55, 541–545. DOI: 10.1248/cpb.55.541.
  • Alizadeh, N.; Khakinahad, R.; Jabbari, A. Spectrophotometric Determination of Lamotrigine in Pharmaceutical Preparations and Urine by Charge-Transfer Complexation. Pharmazie 2008, 63, 791–795. DOI: 10.1691/ph.2008.8616.
  • Rajendraprasad, N.; Basavaiah, K.; Vinay, K. B. Sensitive. Spectrophotometric Determination of Lamotrigine in Bulk Drug and Pharmaceutical Formulations Using Bromocresol Green. Eclet. Quím. 2010, 35, 55–66. DOI: 10.1590/S0100-46702010000100007.
  • Saini, N.; Saini, K. Quantitative Determination of Lamotrigine in Bulk and Dosage Form by UV Spectrophotometry. J. Appl. Pharm. Sci. 2011, 01, 113–116.
  • Rajendraprasad, N.; Basavaiah, K.; Vinay, K. B.; Ramesh, P. J. Simple and Sensitive Spectrophotometric Determination of Lamotrigine in Pure Form and in Dosage Forms. Pharmaceut. Anal. Acta 2012, 3, 1–5. DOI: 10.4172/2153-2435.1000188.
  • Aboul-Kheir, A.; Saleh, H.; El-Henawee, M. M.; Sharf El-Din, M. N. Spectrophotometric Estimation of Lamotrigine and Minoxidil in Bulk and Dosage Forms. Res. J. Pharm. Technol. 2012, 5, 697–708.
  • Jayanna, B. K.; Devaraj, T. D.; Roopa, K. P.; Nagendrappa, G.; Gowda, N. Spectrophotometric Estimation of Lamotrigine in Tablets. Indian J. Pharm. Sci. 2016, 78, 657–662. DOI: 10.1080/22297928.2018.1548944.
  • Najib, F. M.; Mustafa, M. S. Four Spectrophotometric Methods for Simultaneous Determination of Carbamazepine and Lamotrigine in Binary Mixtures and Urine Samples. Malaysian J. Anal. Sci. 2014, 18, 491–506.
  • El-Enany, N. M.; El-Sherbiny, D. T.; Abdelal, A. A.; Belal, F. F. Validated Spectrofluorimetric Method for the Determination of Lamotrigine in Tablets and Human Plasma through Derivatization with o-Phthalaldehyde. J. Fluoresc. 2010, 20, 463–472. DOI: 10.1007/s10895-009-0568-6.
  • Karim, M.; Hoda, M. D.; Youssef, B.; Magdi, A. K.; Mona, M. K. Stress Degradation Assessment of Lamotrigine Using a Validated Stability-Indicating HPTLC Method. J. Chem. 2013, 2013, 608196. DOI: 10.1155/2013/608196.
  • Emami, J.; Ghassami, N.; Ahmadi, F. Development and Validation of a New HPLC Method for Determination of Lamotrigine and Related Compounds in Tablet Formulations. J. Pharm. Biomed. Anal. 2006, 40, 999–1005. DOI: 10.1016/j.jpba.2005.07.045.
  • Pattana, S.; Arunee, S.; Ratchanok, K. Development and Validation of a HPLC Method for a Dissolution Test of Lamotrigine Tablets and Its Application to Drug Quality Control Studies. J. Liq. Chrom. Relat. Tech. 2008, 31, 926–939. DOI: 10.1080/10826070801893615.
  • Nascimento, G. N. L. d.; Pereira, K. C. d. F.; Nishijo, H.; Aversi-Ferreira, T. A. Development and Validation of the Analytical Method by HPLC (HPLC) for Lamotrigine Raw Material. Acta Sci., Health Sci. 2011, 33, 153–157. DOI: 10.4025/actascihealthsci.v33i2.8244.
  • Gangurde, P. K.; Bhaskaran, N. A.; Verma, R.; Jose, J.; Kumar, L. Analytical Method Development Using Central Composite Design for Estimation of Lamotrigine in Lipid Nanoformulation. Mater. Plast. 2020, 57, 223–235. DOI: 10.37358/MP.20.1.5331.
  • Wal, P.; Kumar, B.; Bhandari, A.; Rai, A. K.; Wal, A. Bioanalytical Method Development –Determination of Drugs in Biological Fluids. J. Pharm. Sci. Tech. 2010, 2, 333–347.
  • Lensmeyer, G. L.; Gidal, B. E.; Wiebe, D. A. Optimized High-Performance Liquid Chromatographic Method for Determination Of Lamotrigine in Serum with Concomitant Determination of Phenytoin, Carbamazepine, and Carbamazepine Epoxide. Ther. Drug Monit. 1997, 19, 292–300. DOI: 10.1097/00007691-199706000-00009.
  • Ren, S.; Scheuer, M. L.; Zheng, W. Determination of Lamotrigine in Biologic Materials by a Simple and Rapid Liquid Chromatographic Method. Ther. Drug Monit. 1998, 20, 209–214. DOI: 10.1097/00007691-199804000-00012.
  • Lane, J. B.; Joseph, T. D. Capillary Electrophoresis for Therapeutic Drug Monitoring. Electrophoresis 1998, 19, 2848–2855. DOI: 10.1002/elps.1150191610.
  • Barbosa, N. R.; Mı́dio, A. F. Validated High-Performance Liquid Chromatographic Method for the Determination of Lamotrigine in Human Plasma. J. Chromatogr. B, Biomed. Sci. Appl. 2000, 741, 289–293. DOI: 10.1016/S0378-4347(00)00102-X.
  • Matar, K. M.; Nicholls, P. J.; Tekle, A.; Bawazir, S. A.; Al-Hassan, M. I. Liquid Chromatographic Determination of Six Antiepileptic Drugs and Two Metabolites in Microsamples of Human Plasma. Ther. Drug Monit. 1999, 21, 559–566. DOI: 10.1097/00007691-199910000-00013.
  • Khoschsorur, G. A.; Fruhwirth, F.; Halwachs-Baumann, G. Simple and Rapid HPLC Method for Simultaneous Determination of Multiple Antiepileptic Drugs in Human Serum. Chromatographia 2001, 54, 345–349. DOI: 10.1007/BF02492681.
  • Croci, D.; Salmaggi, A.; de Grazia, U.; Bernardi, G. New High-Performance Liquid Chromatographic Method for Plasma/Serum Analysis of Lamotrigine. Ther. Drug Monit. 2001, 23, 665–668. DOI: 10.1097/00007691-200112000-00012.
  • Queiroz, M. E. C.; Carrilho, E.; Carvalho, D.; Lancas, F. M. Comparison of High-Resolution GC and HPLC for Simultaneous Determination of Lamotrigine and Carbamazepine in Plasma. Chromatographia 2001, 53, 485–489. DOI: 10.1007/BF02491608.
  • Queiroz, M. E. C.; Silva, S. M.; Carvalho, D.; Lanças, F. M. Solid-Phase Microextraction–Liquid Chromatography (SPME–LC) Determination of Lamotrigine Simultaneously with Carbamazepine and Carbamazepine 10, 11-Epoxide in Human Plasma. J. Sep. Sci. 2002, 25, 91–95. DOI: 10.1002/1615-9314(20020101)25:1/2%3C91::AID-JSSC91%3E3.0.CO;2-Z.
  • Queiroz, M. E. C.; Silva, S. M.; Carvalho, D.; Lanças, F. M. Determination of Lamotrigine Simultaneously with Carbamazepine, Carbamazepine Epoxide, Phenytoin, Phenobarbital, and Primidone in Human Plasma by SPME-GC-TSD. J. Chromatogr. Sci. 2002, 40, 219–223. DOI: 10.1093/chromsci/40.4.219.
  • Patil, K. M.; Bodhankar, S. L. High-Performance Thin-Layer Chromatographic Determination of Lamotrigine in Serum. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2005, 823, 152–157. DOI: 10.1016/j.jchromb.2005.06.029.
  • Beck, O.; Ohman, I.; Nordgren, H. K. Determination of Lamotrigine and Its Metabolites in Human Plasma by Liquid Chromatography-Mass Spectrometry. Ther. Drug Monit. 2006, 28, 603–607. DOI: 10.1097/01.ftd.0000245779.64080.30.
  • Pucci, V.; Bugamelli, F.; Baccini, C.; Raggi, M. A. Analysis of Lamotrigine and Its Metabolites in Human Plasma and Urine by Micellar Electrokinetic Capillary Chromatography. Electrophoresis 2005, 26, 935–942. DOI: 10.1002/elps.200410208.
  • Cheng, C. L.; Chou, C. H.; Hu, O. Y. Determination of Lamotrigine in Small Volumes of Plasma by High-Performance Liquid Chromatography. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2005, 817, 199–206. DOI: 10.1016/j.jchromb.2004.12.004.
  • Greiner, C.; Haen, E. Development of a Simple Column-Switching High-Performance Liquid Chromatography (HPLC) Method for Rapid and Simultaneous Routine Serum Monitoring of Lamotrigine, Oxcarbazepine and 10-Monohydroxycarbazepine (MHD). J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2007, 854, 338–344. DOI: 10.1016/j.jchromb.2007.04.006.
  • Saracino, M. A.; Bugamelli, F.; Conti, M.; Amore, M.; Raggi, M. A. Rapid HPLC Analysis of the Antiepileptic Lamotrigine and Its Metabolites in Human Plasma. J. Sep. Sci. 2007, 30, 2249–2255. DOI: 10.1002/jssc.200700110.
  • Vermeij, T. A.; Edelbroek, P. M. Robust Isocratic High Performance Liquid Chromatographic Method for Simultaneous Determination of Seven Antiepileptic Drugs Including Lamotrigine, Oxcarbazepine and Zonisamide in Serum after Solid-Phase Extraction. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2007, 857, 40–46. DOI: 10.1016/j.jchromb.2007.06.023.
  • Greiner-Sosanko, E.; Lower, D. R.; Virji, M. A.; Krasowski, M. D. Simultaneous Determination of Lamotrigine, Zonisamide, and Carbamazepine in Human Plasma by High-Performance Liquid Chromatography. Biomed. Chromatogr. 2007, 21, 225–228. DOI: 10.1002/bmc.753.
  • Ma, C.-L.; Jiao, Z.; Jie, Y.; Shi, X.-J. Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of Their Active Metabolites in Human Plasma. Chroma 2007, 65, 267–275. DOI: 10.1365/s10337-006-0157-7.
  • Bompadre, S.; Tagliabracci, A.; Battino, M.; Giorgetti, R. Determination of Lamotrigine in Whole Blood with on Line Solid Phase Extraction. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2008, 863, 177–180. DOI: 10.1016/j.jchromb.2007.12.020.
  • Zufía, L.; Aldaz, A.; Ibanez, N.; Viteri, C. LC Method for the Therapeutic Drug Monitoring of Lamotrigine: Evaluation of the Assay Performance and Validation of Its Application in the Routine Area. J. Pharm. Biomed. Anal. 2009, 49, 547–553. DOI: 10.1016/j.jpba.2008.11.030.
  • E.R, Tahtamouni, M, A.-W.; Tahboub, Y. R. Simultaneous Analysis of Fluoxetine, Norfluoxetine, Citalopram, and Haloperidol in Plasma by LC–ESI-IT-MS. Chromatographia 2010, 71, 423–430. DOI: 10.1365/s10337-010-1483-3.
  • Heideloff, C.; Dustin, B. R.; Wang, S. A Novel HPLC Method for Quantification of 10 Antiepileptic Drugs or Metabolites in Serum/Plasma Using a Monolithic Column. Ther. Drug Monit. 2010, 32, 102–106. DOI: 10.1097/FTD.0b013e3181c324c8.
  • Lee, W.; Kim, J. H.; Kim, H.; S; Kwon, O. H.; Lee, B. I.; Heo, K. Determination of Lamotrigine in Human Serum by High-Performance Liquid Chromatography–Tandem Mass Spectrometry. Neurol. Sci. 2010, 31, 717–720. DOI: 10.1007/s10072-010-0257-x.
  • AbuRuz, S.; Al-Ghazawi, M.; Al-Hiari, Y. A Simple Dried Blood Spot Assay for Therapeutic Drug Monitoring of Lamotrigine. Chroma 2010, 71, 1093–1099. DOI: 10.1365/s10337-010-1569-y.
  • Antonilli, L.; Brusadin, V.; Filipponi, F.; Guglielmi, R.; Nencini, P. Development and Validation of an Analytical Method Based on High Performance Thin Layer Chromatography for the Simultaneous Determination of Lamotrigine, Zonisamide and Levetiracetam in Human Plasma. J. Pharm. Biomed. Anal. 2011, 56, 763–770. DOI: 10.1016/j.jpba.2011.07.018.
  • Juenke, J. M.; Miller, K. A.; Ford, M.; A; McMillin, G. A.; Johnson-Davis, K. L. A Comparison of Two FDA Approved Lamotrigine Immunoassays with Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. Clin. Chim. Acta 2011, 412, 1879–1882. DOI: 10.1016/j.cca.2011.06.009.
  • Tai, S. S.; Yeh, C. Y.; Phinney, K. W. Development and Validation of a Reference Measurement Procedure for Certification of Phenytoin, Phenobarbital, Lamotrigine, and Topiramate in Human Serum Using Isotope-Dilution Liquid Chromatography/Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2011, 401, 1915–1922. DOI: 10.1007/s00216-011-5251-5.
  • Mennickent, S.; Fierro, R.; Vega, M.; Diego, M.; Godoy, C. Quantification of Lamotrigine in Human Serum by High-Performance Thin-Layer Chromatography. JPC – J. Planar. Chromat. 2011, 24, 222–226. DOI: 10.1556/JPC.24.2011.3.9.
  • Hotha, K. K.; Kumar, S. S.; Bharathi, D. V.; Venkateswarulu, V. Rapid and Sensitive LC-MS/MS Method for Quantification of Lamotrigine in Human Plasma: Application to a Human Pharmacokinetic Study. Biomed. Chromatogr. 2012, 26, 491–496. DOI: 10.1002/bmc.1692.
  • Collins, J. A.; Janis, G. C. Analysis of Selected Anticonvulsants by High Performance Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol. Biol. 2012, 902, 201–209. DOI: 10.1007/978-1-61779-934-1_18.
  • Shibata, M.; Hashi, S.; Nakanishi, H.; Masuda, S.; Katsura, T.; Yano, I. Detection of 22 Antiepileptic Drugs by Ultra-Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry Applicable to Routine Therapeutic Drug Monitoring. Biomed. Chromatogr. 2012, 26, 1519–1528. DOI: 10.1002/bmc.2726.
  • Baldelli, S.; Castoldi, S.; Charbe, N.; Cozzi, V.; Fucile, S.; Cattaneo, D.; Clementi, E. Comparison of the QMS Analyzer with HPLC-UV for the Quantification of Lamotrigine Concentrations in Human Plasma Samples. Ther. Drug Monit. 2015, 37, 689–694. DOI: 10.1097/FTD.0000000000000202.
  • Ibrahim, F. A.; El-Yazbi, A. F.; Barary, M. A.; Wagih, M. M. Sensitive Inexpensive HPLC Determination of Four Antiepileptic Drugs in Human Plasma: Application to PK Studies. Bioanalysis 2016, 8, 2219–2234. DOI: 10.4155/bio-2016-0211.
  • Kumar, A.; Joshi, M. D.; Gupta, A.; Gurule, S.; Kumar, R.; Rahul, K.; Nishant, C.; Aditya, P.; Manisha, R. Development and Validation of Analytical Method for the Estimation of Lamotrigine in Human Plasma. World J. Pharm. Pharm. Sci. 2017, 6, 2658–2669. DOI: 10.20959/wjpps20178-9967.
  • Namdev, K. K.; Dwivedi, J.; Chilkoti, D. C.; Sharma, S. A Simple, Rapid and Stability Indicating Validated Method for Quantification of Lamotrigine in Human Plasma and Dry Plasma Spot Using LC-ESI-MS/MS: Application in Clinical Study. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2018, 1072, 362–369. DOI: 10.1016/j.jchromb.2017.11.040.
  • Itabashi, S.; Bito, R.; Nishina, M.; Fukumoto, M.; Soda, M.; Doi, M.; Usui, S.; Kitaichi, K. Determination of Lamotrigine in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry. Neuropsychopharmacol. Rep. 2019, 39, 48–55. DOI: 10.1002/npr2.12045.
  • Palte, M. J.; Basu, S. S.; Dahlin, J. L.; Gencheva, R.; Mason, D.; Jarolim, P.; Petrides, A. K. Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting. Ther. Drug Monit. 2018, 40, 469–476. DOI: 10.1097/FTD.0000000000000516.
  • Liu, T.; Kotha, R. R.; Jones, J. W.; Polli, J. E.; Kane, M. A. Fast Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of Eight Antiepileptic Drugs and an Active Metabolite in Human Plasma Using Polarity Switching and Timed Selected Reaction Monitoring. J. Pharm. Biomed. Anal. 2019, 176, 1–8. DOI: 10.1016/j.jpba.2019.112816.
  • Jin, S.; Zhao, Q.; Zhang, Z.; Zhao, Z.; Mei, S. Development and Validation of an Improved HPLC-UV Method for Simultaneous Determination of Lamotrigine and Oxcarbazepine and Its Active Metabolite 10,11-Dihydro-10-Hydroxycarbazepine in Human Blood Plasma and Comparison with an UHPLCMS/MS Method. Anal. Sci. Technol. 2019, 10, 1–10. DOI: 10.1186/s40543-019-0198-9.
  • Shahdoustia, P.; Aghamohammadia, M.; Fallahia, E.; Kalhor, H. Simultaneous Determination of Lamotrigine and Carbamazepinein Plasma Using Ultrasound-Assisted Emulsification Microextraction-HPLC. J. Anal. Chem. 2020, 75, 622–628. DOI: 10.1134/S1061934820050160.
  • Abou-Tale, N. H.; El-Sherbiny, D. T.; El-Enany, N. M.; El-Subbagh, H. I. Multiobjective Optimization of Microemulsion-Thin Layer Chromatography with Image Processing as Analytical Platform for Determination of Drugs in Plasma Using Desirability Functions. J. Chromatogr. A 2020, 1619, 1–9. DOI: 10.1016/j.chroma.2020.460945.
  • Zhao, Q.; Jin, S.; Liu, Q.; Zhao, Z.; Feng, W.; Mei, S. Simultaneous Determination of Lamotrigine, Topiramate, Oxcarbazepine, and 10,11-Dihydro-10-Hydroxycarbazepine in Human Blood Plasma by UHPLC-MS/MS. Curr. Anal. Chem. 2020, 16, 1010–1021. DOI: 10.2174/1573411016666200108143049.
  • Biddlecombe, A.; Dean, T. K. L.; Smith, C. D.; Jeal, S. C. Validation of a Radioimmunoassay for the Determination of Human Plasma Concentrations of Lamotrigine. J. Pharmaceut. Biomed. 1990, 8, 691–694. DOI: 10.1016/0731-7085(90)80104-W.
  • Shihabi, K.; Oles, K. S. Serum Lamotrigine Analysis by Capillary Electrophoresis. J. Chromatogr. B 1996, 683, 119–123. DOI: 10.1016/0378-4347(96)00146-6.
  • Burgoa Calvo, M. E.; Domínguez Renedo, O.; Arcos Martínez, M. J. Determination of Lamotrigine by Adsorptive Stripping Voltammetry Using Silver Nanoparticle-Modified Carbon Screen-Printed Electrodes. Talanta 2007, 74, 59–64. DOI: 10.1016/j.talanta.2007.05.026.
  • Smarzewska, S.; Guziejewski, D.; Leniart, A.; Ciesielski, W. Nanomaterials vs Amalgam in Electroanalysis: Comparative Electrochemical Studies of Lamotrigine. J. Electrochem. Soc. 2017, 164, B321–B329. DOI: 10.1149/2.0221707jes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.